Aprea Therapeutics (APRE) Preferred Stock Liabilities (2018 - 2026)
Aprea Therapeutics (APRE) reported Preferred Stock Liabilities of $727,361 for Q2 2026, unchanged from $727,361 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Aprea Therapeutics (APRE) Preferred Stock Liabilities (2018 - 2026) Analysis & Trends
Dating back to Q4 2018, Aprea Therapeutics' Preferred Stock Liabilities record includes 19 quarters.
- Preferred Stock Liabilities has a three-year compound annual growth rate of -17.8% (FY2022 to FY2025).
- By year, Preferred Stock Liabilities came in at $1.31 million in FY2024 (unchanged), $1.31 million in FY2023 (unchanged) and $1.31 million in FY2022.
- Five-year quarterly Preferred Stock Liabilities spans a low of $727,361 in Q2 2025 and a high of $68.78 million in Q2 2022.
- Over the past five years, the year-over-year decline in Preferred Stock Liabilities ranged from 0.0% (Q2 2026) to 98.1% (Q2 2023).
- Per Business Quant data, the three quarters before Q2 2026 came in at $727,361 (Q1 2026), $727,361 (Q4 2025) and $727,361 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Aprea Therapeutics | 40.11 Mn | 40.11 Mn | - | 727,361.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 727,361.00 |
| Mar 31, 2026 | 727,361.00 |
| Dec 31, 2025 | 727,361.00 |
| Sep 30, 2025 | 727,361.00 |
| Jun 30, 2025 | 727,361.00 |
| Mar 31, 2025 | 1.31 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.31 Mn |
| Sep 30, 2023 | 1.31 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 68.78 Mn |
| Sep 30, 2019 | 236.38 Mn |
| Dec 31, 2018 | 112.59 Mn |
API Access
Aprea Therapeutics Preferred Stock Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=APRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-stock-liabilities", "ticker": "APRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=APRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();